116 related articles for article (PubMed ID: 9389547)
21. Characterization of prolactin-releasing factor in the rat posterior pituitary.
Hyde JF; Ben-Jonathan N
Endocrinology; 1988 Jun; 122(6):2533-9. PubMed ID: 3131118
[TBL] [Abstract][Full Text] [Related]
22. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo.
Steinmetz R; Brown NG; Allen DL; Bigsby RM; Ben-Jonathan N
Endocrinology; 1997 May; 138(5):1780-6. PubMed ID: 9112368
[TBL] [Abstract][Full Text] [Related]
23. Pituitary hormone gene expression and secretion in human growth hormone-releasing hormone transgenic mice: focus on lactotroph function.
Moore JP; Cai A; Hostettler ME; Arbogast LA; Voogt JL; Hyde JF
Endocrinology; 2000 Jan; 141(1):81-90. PubMed ID: 10614626
[TBL] [Abstract][Full Text] [Related]
24. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
Castillo AI; Aranda A
Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
[TBL] [Abstract][Full Text] [Related]
26. Estrogen downregulates neuronal nitric oxide synthase in rat anterior pituitary cells and GH3 tumors.
Qian X; Jin L; Lloyd RV
Endocrine; 1999 Oct; 11(2):123-30. PubMed ID: 10709758
[TBL] [Abstract][Full Text] [Related]
27. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
Song JY; Jin L; Lloyd RV
Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
[TBL] [Abstract][Full Text] [Related]
28. Pituitary-type transcription of the human prolactin gene in the absence of Pit-1.
Gellersen B; Kempf R; Telgmann R; DiMattia GE
Mol Endocrinol; 1995 Jul; 9(7):887-901. PubMed ID: 7476971
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells.
Dembinski TC; Leung CK; Shiu RP
Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846
[TBL] [Abstract][Full Text] [Related]
30. An alternatively spliced form of Pit-1 represses prolactin gene expression.
Day RN; Day KH
Mol Endocrinol; 1994 Mar; 8(3):374-81. PubMed ID: 8015554
[TBL] [Abstract][Full Text] [Related]
31. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
32. Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro.
Spangelo BL; Farrimond DD; Thapa M; Bulathsinghala CM; Bowman KL; Sareh A; Hughes FM; Goldstein AL; Badamchian M
Endocrinology; 1998 Apr; 139(4):2155-62. PubMed ID: 9529005
[TBL] [Abstract][Full Text] [Related]
33. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
34. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
Coleman DT; Chen X; Sassaroli M; Bancroft C
Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
[TBL] [Abstract][Full Text] [Related]
35. Effects of calcium and calcium ionophores on prolactin gene expression in GH3 and 235-1 rat pituitary tumor cells.
Delidow BC; Lail-Trecker M; White BA
Mol Endocrinol; 1992 Aug; 6(8):1268-76. PubMed ID: 1406704
[TBL] [Abstract][Full Text] [Related]
36. Insulin regulates prolactin secretion and messenger ribonucleic acid levels in pituitary cells.
Prager D; Yamashita S; Melmed S
Endocrinology; 1988 Jun; 122(6):2946-52. PubMed ID: 3286229
[TBL] [Abstract][Full Text] [Related]
37. The posterior pituitary contains a potent prolactin-releasing factor: in vivo studies.
Hyde JF; Ben-Jonathan N
Endocrinology; 1989 Aug; 125(2):736-41. PubMed ID: 2526728
[TBL] [Abstract][Full Text] [Related]
38. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice.
Maki K; Miyoshi I; Kon Y; Yamashita T; Sasaki N; Aoyama S; Takahashi E; Namioka S; Hayashizaki Y; Kasai N
Mol Cell Endocrinol; 1994 Nov; 105(2):147-54. PubMed ID: 7859921
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin is the major prolactin releasing factor in the posterior pituitary.
Mori M; Vigh S; Miyata A; Yoshihara T; Oka S; Arimura A
Endocrinology; 1990 Feb; 126(2):1009-13. PubMed ID: 2298152
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional effects in GH3 cells of Gs alpha mutants associated with human pituitary tumors: stimulation of adenosine 3',5'-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A.
Gaiddon C; Mercken L; Bancroft C; Loeffler JP
Endocrinology; 1995 Oct; 136(10):4331-8. PubMed ID: 7664652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
